Literature DB >> 2433083

Analysis of antigen specific T cell helper function in first degree relatives of patients with systemic lupus erythematosus (SLE).

R Segal, C Brautbar, D Katz, Y Shalev, Z Bentwich, E Mozes.   

Abstract

Fourteen families with first degree relatives of patients with systemic lupus erythematosus (SLE) were studied for the ability of their members to respond to the synthetic polypeptide antigen (T,G)-A-L. The family members were also tested for their HLA determinants. All SLE patients tested responded to (T,G)-A-L as measured by the production of (T,G)-A-L specific T cell helper factors by their antigen activated T cells, confirming our previous findings that 100% of SLE donors responded to (T,G)-A-L in contrast to 50% responders in a control population of healthy donors. The general defect in the regulation of immune responses in SLE patients was further indicated by the demonstration that an SLE patient who is a daughter of non-responder parents to (T,G)-A-L, responded to this genetically regulated antigen. In contrast to our observations with SLE patients, the genetic regulation of the ability to respond to (T,G)-A-L was shown not to be impaired in healthy first degree family members of SLE patients and the segregation of the immune response potential in these families was as expected from an inherited dominant trait.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2433083      PMCID: PMC1542651     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Studies on the chemical basis of the antigenicity of proteins. 5. Synthesis, characterization and immunogenicity of some multichain and linear polypeptides containing tyrosine.

Authors:  M SELA; S FUCHS; R ARNON
Journal:  Biochem J       Date:  1962-10       Impact factor: 3.857

2.  Familial lupus. Family studies of HLA and serologic findings.

Authors:  L G Cleland; D A Bell; M Willans; B C Saurino
Journal:  Arthritis Rheum       Date:  1978-03

3.  B-lymphocyte alloantigens associated with systemic lupus erythematosus.

Authors:  J L Reinertsen; J H Klippel; A H Johnson; A D Steinberg; J L Decker; D L Mann
Journal:  N Engl J Med       Date:  1978-09-07       Impact factor: 91.245

Review 4.  Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets.

Authors:  S R Block; J B Winfield; M D Lockshin; W A D'Angelo; C L Christian
Journal:  Am J Med       Date:  1975-10       Impact factor: 4.965

Review 5.  Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture.

Authors:  P I Terasaki; D Bernoco; M S Park; G Ozturk; Y Iwaki
Journal:  Am J Clin Pathol       Date:  1978-02       Impact factor: 2.493

Review 6.  Studies in familial systemic lupus erythematosus.

Authors:  F C Arnett; L E Shulman
Journal:  Medicine (Baltimore)       Date:  1976-07       Impact factor: 1.889

7.  Familial systemic lupus erythematosus.

Authors:  K J Buckman; S K Moore; A J Ebbin; M B Cox; E L Dubois
Journal:  Arch Intern Med       Date:  1978-11

8.  Immunologic observations on 9 sets of twins either concordant or discordant for SLE.

Authors:  S R Block; M D Lockshin; J B Winfield; M E Weksler; M Imamura; R J Winchester; R C Mellors; C L Christian
Journal:  Arthritis Rheum       Date:  1976 May-Jun

9.  Hereditary C2 deficiency: Genetic studies and association with the HL-A system.

Authors:  N K Day; R L'Esperance; R A Good; A F Michael; J A Hansen; B Dupont; C Jersild
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

10.  Immunization of dissociated spleen cell cultures from normal mice.

Authors:  R I Mishell; R W Dutton
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

View more
  1 in total

1.  Anti-DNA idiotype- and anti-idiotype-specific T cell responses in patients with systemic lupus erythematosus and their first-degree relatives.

Authors:  S Mendlovic; R Segal; Y Shoenfeld; E Mozes
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.